What to Report
Oklahoma Administrative Code (OAC) 310:515 specifies which diseases and conditions are reportable and the timeframe and methods for reporting.
Reportable Disease Rules – OAC 310:515 (41k.pdf)
The Disease Reporting Manual further defines the specifics for clinical and laboratory reporting requirements for diseases and conditions. In addition to reporting requirements, the manual contains guidance in determining if an event should be reported, and specifies which specimens and isolates are required to be forwarded to the OSDH Public Health Laboratory. The Oklahoma Disease Reporting Manual 2009 is not currently available. Please continue to use the 2008 manual as a reference until the new manual is posted to this webpage.
Oklahoma Disease Reporting Manual 2008 (4,350k.pdf)
Reportable diseases and conditions poster(s):
Reportable Diseases/Conditions Poster for Healthcare Providers (28k.pdf)
Reportable Pathogens Poster for Laboratories (31k.pdf)
The following diseases are to be reported to the OSDH by PHIDDO or telephone immediately upon suspicion, diagnosis, or positive test:
| Anthrax |
Hepatitis B during
pregnancy (HBsAg+) |
Rabies |
| Bioterrorism-suspected disease |
Measles (Rubeola) |
Smallpox |
| Botulism |
Meningococcal invasive
disease |
Tularemia |
| Diphtheria |
Outbreaks of apparent
infectious disease |
Typhoid fever |
| H. influenzae (sterile site) |
Plague |
Viral hemorrhagic fever |
| Hepatitis A (Anti-HAV-IgM+) |
Poliomyelitis |
The following diseases are to be reported to the OSDH by PHIDDO, telephone, or fax within one
business day:
| Acid Fast Bacillus (AFB) positive smear |
Lyme disease |
| AIDS (Acquired Immunodeficiency Syndrome) |
Malaria |
| Arboviral Infections |
Mumps |
| Brucellosis |
Pertussis |
| Campylobacteriosis |
Psittacosis |
| Congenital rubella syndrome |
Q Fever |
| Cryptosporidiosis |
Rocky Mountain spotted fever |
| Cyclosporiasis |
Rubella |
| Dengue fever |
Salmonellosis |
| E. coli O157, O157:H7 or a Shiga toxin producing E. coli (STEC) |
Shigellosis |
| Ehrlichiosis |
Staphylococcus aureus(VISA or VRSA) |
| Giardiasis |
Streptococcus,group A, invasive disease |
| Hantavirus pulmonary syndrome |
Streptococcus pneumoniae invasive disease, children <5 years |
| Hemolytic uremic syndrome, postdiarrheal |
Syphilis |
| Hepatitis B (HBsAg+, anti-HBc IgM+, HBeAg+, and/or HBV DNA+) 1 |
Tetanus |
| Hepatitis C (confirmed by RIBA or NAT for HCV RNA, or s/co ratio or index) 1 |
Trichinellosis |
| Human Immunodeficiency Virus (HIV) infection |
Tuberculosis |
| Influenza associated pediatric mortality |
Unusual syndrome or uncommon disease |
| Legionellosis |
Vibriosis including cholera |
| Leptospirosis |
Yellow Fever |
| Listeriosis |
|
1- with entire Hepatitis panel results
The following diseases are to be reported to the OSDH by PHIDDO, telephone, or fax within one month:
| CD4 Cell Count < 500 with cell count% |
Creutzfeldt-Jakob disease |
HIV viral load |
| Chlamydia infections (C. trachomatis) |
Gonorrhea |
Pelvic inflammatory disease |
Isolates of the following organisms must be sent to the OSDH Public Health Laboratory: P.O. Box 24106 OKC, OK 73214:
| Bacillus anthracis |
N. meningitidis (sterile site isolates only) |
| Brucella spp. |
Plasmodium spp. |
| E. coli O157, O157:H7 or a Shiga toxin producing E. coli (STEC) |
Salmonella spp. |
| Francisella tularensis |
Staphylococcus aureus(VISA or VRSA) |
| H. influenzae (sterile site isolates only) |
Vibrio spp. |
| Listeria spp. (sterile site isolates only) |
Yersinia spp. |
| Mycobacterium tuberculosis |
|
![<{$map[0].NAME}>](/triton/defaults/images/right_health.jpg)
